Welcome to kongre.net

TI

SummitIn personPast event

9th TPD & Induced Proximity Summit

Hosted by Hanson Wade

26 – 29 October 2026
The Omni Boston Hotel at the Seaport, Boston, United States of America
Health SciencesPharmacy & Pharmaceutical Sciences

Let others know you'll be there. This does not register you for the event.

Welcome to kongre.net

Welcome to kongre.net

Official website

Programme

Published

56 sessions across 4 days

3 rooms · 60 speakers

Browse programme

Registration

Event has ended

Registration is handled by the organiser

Fees are listed on this page

View registration details

Key facts

9th TPD & Induced Proximity Summit is a summit held 26 – 29 October 2026 in The Omni Boston Hotel at the Seaport, Boston, United States of America, organised by Hanson Wade.

Dates:: 26 – 29 October 2026
Format:: In person
Venue:: The Omni Boston Hotel at the Seaport, Boston, United States of America
Subjects:: Pharmacy & Pharmaceutical Sciences
Organiser:: Hanson Wade
Official website:: proteindegradation.com

The 9th TPD & Induced Proximity Summit is the world's definitive forum dedicated to targeted protein degradation and induced proximity drugs. Organised by Hanson Wade, the event takes place from October 26-29, 2026, at The Omni Boston Hotel at the Seaport in Boston, MA. Gathering over 350 attendees and 80+ world-class speakers from academia, start-ups, biotechs, and pharma, the summit connects the full TPD ecosystem across four days of deep scientific exploration spanning early discovery to clinical development.

Programme highlights

View full programme

Mon, 26 Oct 2026Chair’s Opening RemarksPlenary12 sessions this day
Tue, 27 Oct 2026Chair’s Opening RemarksPlenary11 sessions this day
Wed, 28 Oct 2026Chair’s Opening RemarksPlenary13 sessions this day

Keynote speakers

Keynote
Stuart Schreiber
Professor, Harvard Medical School
Principles Underlying Induced Proximity Drugs: Lessons from Early Development to the Present
Keynote
Randy Teel
President & Chief Executive Officer, Arvinas, Inc.
Degradation Delivered – What the First TPD Approval Means for the Future of the Field

Speakers

View all 62 speakers

Andrew Buesking
Prelude Therapeutics
Identification of First-in-Class KAT6A Degraders Leading to Potent & KAT6A-Selective Oral Development Candidate PRT13722
Meizhong Jin
AstraZeneca
Linking Molecular Glue Binding Kinetics to Functional Performance Through Quantitative Modeling
Jeffrey Skolnick
Georgia Institute of Technology
GlueFinder: A Data-Driven Framework for the Rational Discovery of Molecular Glues
Santha Santhakumar
University of Toronto
Direct-to-Biology Discovery of Potent FBXO22 Homo-PROTACs
Evris Gavathiotis
Albert Einstein College of Medicine
αC-Helix–Proximal Allostery as a Platform for Selective Kinase Modulation & Complex Degradation +1 more
Maxwell Sherman
Serinus Biosciences
Mechanism-Agnostic Molecular Glue Discovery in Living Cells
Mark Shearman
Ubiquitx
Target Discover & Validation Leveraging AI-Native Chimeric Ligands for Induced Proximity
Tomohiro Watanabe
Ajinomoto Bio-Pharma Services
Enabling Next-Generation Targeted Protein Degradation through AJICAP® Site-Specific Conjugation and Linker Technologies

Venue & travel The Omni Boston Hotel at the SeaportBoston, United States of AmericaVenue details About the organiser Hanson Wade4 more events from this organiserOrganiser profile Who is going? See who attended this eventSee who is going

Organiser and contact

Host organisation

Hanson Wade 4 more events from Hanson Wade

Contact

Event secretary:: Stacey Millard
Email:: [email protected]

Advertisement

Related events